In addition, CD4+ T cells were demonstrated to mediate tumor-antigen-mediated killing of tumor cells, highlighting the importance to understand the functional heterogeneity of the different T cell subsets in tumors (24, 44, 45). This evidence concerns the gene CD4 and neoplasm.